Alcon Labs Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ALCON LABS, and what generic alternatives to ALCON LABS drugs are available?
ALCON LABS has eighteen approved drugs.
There are thirty-nine US patents protecting ALCON LABS drugs.
There are two hundred and seventeen patent family members on ALCON LABS drugs in thirty-one countries and twenty-seven supplementary protection certificates in ten countries.
Summary for Alcon Labs
| International Patents: | 217 |
| US Patents: | 39 |
| Tradenames: | 15 |
| Ingredients: | 13 |
| NDAs: | 18 |
Drugs and US Patents for Alcon Labs
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 11,219,596 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 10,532,993 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Alcon Labs Inc | RHOPRESSA | netarsudil mesylate | SOLUTION/DROPS;OPHTHALMIC | 208254-001 | Dec 18, 2017 | RX | Yes | Yes | 10,882,840 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Alcon Labs Inc | PATADAY ONCE DAILY RELIEF | olopatadine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 206276-001 | Jan 30, 2015 | OTC | Yes | Yes | 9,533,053 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| Alcon Labs Inc | EYSUVIS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210933-001 | Oct 26, 2020 | RX | Yes | Yes | 10,993,908 | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| Alcon Labs Inc | ROCKLATAN | latanoprost; netarsudil dimesylate | SOLUTION/DROPS;OPHTHALMIC | 208259-001 | Mar 12, 2019 | RX | Yes | Yes | 8,394,826 | ⤷ Try a Trial | Y | Y | ⤷ Try a Trial | ||
| Alcon Labs Inc | INVELTYS | loteprednol etabonate | SUSPENSION/DROPS;OPHTHALMIC | 210565-001 | Aug 22, 2018 | RX | Yes | Yes | 10,646,437 | ⤷ Try a Trial | Y | ⤷ Try a Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Alcon Labs
International Patents for Alcon Labs Drugs
| Country | Patent Number | Estimated Expiration |
|---|---|---|
| Japan | 2012530712 | ⤷ Try a Trial |
| European Patent Office | 3354643 | ⤷ Try a Trial |
| Mexico | 2021007794 | ⤷ Try a Trial |
| Russian Federation | 2563125 | ⤷ Try a Trial |
| South Korea | 20150006868 | ⤷ Try a Trial |
| New Zealand | 742005 | ⤷ Try a Trial |
| Japan | 7320219 | ⤷ Try a Trial |
| >Country | >Patent Number | >Estimated Expiration |
Supplementary Protection Certificates for Alcon Labs Drugs
| Patent Number | Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|---|
| 3043773 | 2022C/520 | Belgium | ⤷ Try a Trial | PRODUCT NAME: MOMETASONE OF EEN ZOUT HIERVAN EN OLOPATADINE OF EEN ZOUT HIERVAN; AUTHORISATION NUMBER AND DATE: BE595626 20220203 |
| 3461484 | 132021000000068 | Italy | ⤷ Try a Trial | PRODUCT NAME: COMBINAZIONE DI LATANOPROST E NETARSUDIL(ROCLANDA); AUTHORISATION NUMBER(S) AND DATE(S): EU/1/20/1502, 20210108 |
| 3053913 | 2020/016 | Ireland | ⤷ Try a Trial | PRODUCT NAME: NETARSUDIL, OR AN ENANTIOMER, DIASTEREOMER, SALT OR SOLVATE THEREOF; REGISTRATION NO/DATE: EU/1/19/1400 20191121 |
| 1631293 | 2014/041 | Ireland | ⤷ Try a Trial | PRODUCT NAME: BRIMONIDINE AND PHARMACEUTICALLY ACCEPTABLE SALTS THEREOF; REGISTRATION NO/DATE: EU/1/13/904 20140221 |
| 1631293 | 92462 | Luxembourg | ⤷ Try a Trial | PRODUCT NAME: BRIMONIDINE ET SES SELS PHARMACEUTIQUES POUR L UTILISATION COMME MEDICAMENT POUR LE TRAITEMENT DES ROUGEURS INDUITES PAR LA ROSACEA.FIRST REGISTRATION: 20140225 |
| 3053913 | 122020000016 | Germany | ⤷ Try a Trial | PRODUCT NAME: NETARSUDIL, ODER EIN ENANTIOMER, DIASTEREOMER, SALZ ODER SOLVAT DAVON; REGISTRATION NO/DATE: EU/1/19/1400 20191119 |
| 1631293 | 300683 | Netherlands | ⤷ Try a Trial | PRODUCT NAME: BRIMONIDINE EN FARMACEUTISCH AANVAARDBARE ZOUTEN DAARVAN VOOR TOEPASSING ALS GENEESMIDDEL VOOR DE BEHANDELING VAN DOOR ROSACEA GEINDUCEERDE ROODHEID; REGISTRATION NO/DATE: EU/1/13/904 20140225 |
| >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration | >SPC Description |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
